AKER Market Cap History
Below is a table of the AKER market cap history going back to 1/23/2014:

Date AKER Market Cap
1/23/201423.63M
3/25/201423.74M
5/13/201418.85M
8/12/201417.54M
11/13/201415.51M
3/23/201521.94M
5/13/201524.03M
8/17/201519.45M
11/10/201515.69M
3/25/20169.77M
5/11/20168.46M
8/8/201617.07M
11/8/201617.99M
4/5/201714.17M
5/15/201715.57M
8/14/20179.17M
11/10/20177.24M
3/15/201855.74M
7/13/201833.41M
8/13/201825.41M
11/8/201828.03M
3/29/201912.11M
5/20/20199.02M
8/9/20195.38M
7/17/20186.33M
11/13/20193.94M
11/25/20193.70M
3/24/20206.40M
8/13/202047.63M
11/16/202017.19M
2/26/202155.45M

Also see: AKER Shares Outstanding History
and AKER YTD Return
AKER Historical Market Cap:
+12.77% CAGR
AKER Historical Market Cap: +12.77% CAGR

Mouse over chart for data details
1/23/2014 ...2/26/2021
Akers Biosciences is a provider of rapid diagnostic solutions. Co.'s commercialized product portfolio incorporates the following proprietary platform testing and sample preparation technologies: Particle Immuno-Filtration Assay, an immunoassay method based on the selective filtration of dyed microparticles coated with antigen or antibody; MicroParticle Catalyzed Biosensor, which permits the identification of medical conditions through biomarkers in exhaled breath; and Rapid Blood Cell Separation Technology, which increases the rate at which a test result is obtained as the often-required sample preparation step is abbreviated. We show 31 historical shares outstanding datapoints in our AKER shares outstanding history coverage, used to compute AKER market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing AKER market cap history over the course of time is important for investors interested in comparing AKER's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of AKER versus a peer is one thing; comparing AKER market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like AKER can fluctuate over the course of history. With this page we aim to empower investors researching AKER by allowing them to research the AKER market cap history.
Quotes delayed 20 minutes
Get Free SEC filing alerts for AKER:
AKER SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Akers Biosciences (AKER) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

AKRX Market Cap History
ALBO Market Cap History
ALC Market Cap History
ALDR Market Cap History
ALDX Market Cap History
ALGN Market Cap History
ALIM Market Cap History
ALKS Market Cap History
ALNA Market Cap History
ALNY Market Cap History
More Healthcare companies »

 

AKER Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2021, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.